Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae?

"Declarations Ethics approvalThe study was approved by the Ethics Committee of Verona University Hospital (prog. 2785CESC Verona-Rovigo). Consent to participate/publicationInformed consent was obtained from each included patient. Conflict of interestS. Ferrari received support for attending scientific meetings by Shire, Sanofi Genzyme, and Euroimmun. F. Piraino is an employee of the Quanterix Corporation. S. Mariotto received support for attending scientific meetings by Merck and Euroimmun and received speaker honoraria from Biogen. The other authors report no competing interests. Conflict of interest S. Ferrari received support for attending scientific meetings by Shire, Sanofi Genzyme, and Euroimmun. F. Piraino is an employee of the Quanterix Corporation. S. Mariotto received support for attending scientific meetings by Merck and Euroimmun and received speaker honoraria from Biogen. The other authors report no competing interests."

"Funding Open access funding provided by Università degli Studi di Veronawithin the CRUI-CARE Agreement. The study was partially supported by grant Brain Research Foundation Verona 2020 and ENACT from the Cariverona Foundation, Italy."